Nigel Farage’s Action on World Health launches review into World Health Organization
LONDON, Dec. 2, 2024 /PRNewswire/ — Action on World Health (AWH), the international campaign group committed to reforming the World Health Organization (WHO), has launched the ‘Bell Review’; a working group of 9 experts including former WHO and United Nations (UN) officers and advi
Hurom Wins Patent Infringement Ruling Against NUC(Kuvings) on Amazon in the U.S.
Sales Ban Enforced on NUC(Kuvings)‘s Primary Juicer Models on Amazon SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ — Hurom, a global leader in juicing technology as the pioneer of low-speed extraction methods, announced successful enforcement of its patent against NUC(Kuvings) on Amazon&
CNOOC Limited Brings On-stream Huizhou 26-6 Oilfield Development Project
HONG KONG, Dec. 1, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announces that Huizhou 26-6 Oilfield Development Project has commenced production. The project is located in the Pearl River Mouth Basin, with
Trip.com Group’s Country Retreats Featured in ESG 20 Report by UN Global Compact
The UNGC ESG 20 Report highlights Trip.com Group’s role in advancing sustainable travel, with its ‘Country Retreats’ project as a model The Group’s commitment to sustainability extends across its offerings, from lower-carbon transportation options to accommodation SINGAPORE,
" title="“Make it real ninja” Real ninja teaches martial arts at a famous temple in Tokyo-Sumida -17th January to 2th February 2025
TOKYO, Dec. 1, 2024 /PRNewswire/ — The Sumida-Ryogoku area of Tokyo, famous as the home of sumo, Japan’s national sport, is home to many famous historical sites that give a glimpse into the country’s history. In the Ryogoku area, you can experience being a ninja at Ekoin Temple,
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong
SHANGHAI, Dec. 2, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that Departme
Media Advisory – Deputy Prime Minister’s itinerary for Monday, December 2, 2024
OTTAWA, ON, Dec. 1, 2024 /CNW/ – Note: All times local. Ottawa, Ontario Private meetings. 5:30 p.m. The Deputy Prime Minister will chair a meeting of the Cabinet Committee on Canada-U.S. Relations. Closed to media. This document is also available at https://deputypm.canada.ca/en SOURCE Deputy
ROLLER Recognized on the AFR Fast 100 List for Exceptional International Growth
ROLLER’s purpose is to help create experiences that bring joy and happiness to the world. It accomplishes this by connecting attractions venues with tech solutions that combine power with simplicity. MELBOURNE, Australia, Dec. 2, 2024 /PRNewswire/ — ROLLER, an all-in-one venue managemen
Media Advisory – Prime Minister’s itinerary for Monday, December 2, 2024
OTTAWA, ON, Dec. 1, 2024 /CNW/ – National Capital Region, Canada No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
RTO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rentokil Initial Plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Dec. 1, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rentokil Initial Plc (“Rentokil” or “the Company”) (NYSE:
